September 1, 2015Open Access
View Full PaperODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia
Key Points
Key points are not available for this paper at this time.
Abstract
Cinicaltrials.gov (identifiers: NCT01623115; NCT01709500).